Le Lézard
Classified in: Health, Covid-19 virus
Subjects: TDS, TRI

Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024


GAITHERSBURG, Md., April 1, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, will showcase continued progress on data from its updated COVID-19 vaccine (NVX-CoV2601) and provide an overview of its influenza and COVID-19-Influenza Combination (CIC) vaccine candidates at the World Vaccine Congress 2024 (WVC) in Washington, DC, April 2 to 4, 2024.

New data from Novavax's ongoing research on its updated XBB.1.5 COVID-19 vaccine in participants who previously received an mRNA vaccine showed robust neutralizing antibody titers for the XBB.1.5 subvariant as well as for the currently circulating JN.1 subvariant. Data also showed that the vaccine's safety and reactogenicity profile was consistent with its prototype vaccine (NVX-CoV2373).

Differences observed in immunoglobulin (IgG) subclass responses and Fc?-mediated effector functions following mRNA and protein-based COVID-19 vaccinations will be shared.

Novavax will also discuss its influenza and CIC vaccine candidates, including a recap of data to date and the timeline for the Phase 3 trial anticipated to start during the second half of 2024.

Dr. Robert Walker, Chief Medical Officer, Novavax, will participate in a panel discussion on The Future of COVID-19 Vaccinations on April 3, exploring the benefits of developing broadly protective antigens or combination vaccines.

Novavax presentations during WVC:

Mallory, R

Safety and
Immunogenicity of the
Novavax XBB.1.5 SARS-
CoV-2 Vaccine in
Previously mRNA
Vaccinated Participants

Oral Presentation

April 3, 2024

10:10am (EDT)

Kalkeri, R

Distinct Differences in
IgG4 switch and Fc
effector functions
between mRNA and
Novavax protein-based
COVID Vaccination

Oral Presentation

April 3, 2024

10:25am (EDT)

Mallory, R

Update on Novavax
influenza and COVID-
influenza combination
vaccine

Oral Presentation

April 3, 2024

2:40pm (EDT)

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes a vaccine for COVID-19 and influenza combined. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Erika Schultz
240-268-2022
[email protected]

Media
Ali Chartan
240-720-7804
[email protected]

Novavax logo (PRNewsfoto/NOVAVAX, INC)

 

SOURCE NOVAVAX, INC


These press releases may also interest you

at 12:27
Sun Life steps up and pledges more than $1 million for youth mental health
Ahead of National Child and Youth Mental Health Day tomorrow, Sun Life is pleased to announce a $1,050,000 million commitment over three years in support of mental health programs for at-risk and marginalized youth in Canada. This commitment will be...

at 12:26
Africa and the Americas solidify partnership to restore soils, under initiative led by AGRA and IICA
(IICA) ? The Alliance for a Green Revolution in Africa (AGRA) and the Inter-American Institute for Cooperation on Agriculture (IICA) launched the "Living Soils" initiative, which, based on its successful implementation in the Americas, will seek to...

at 12:24
Statement - Celebrating Indigenous Nurses during National Nursing Week
The Minister of Indigenous Services, Patty Hajdu, issued the following statement today: "When Lindsay Iron graduated from her university nursing program, she was driven by a single goal: to return home and serve her people. Since then, Lindsay, an...

at 12:12
FDI Summit Costa Rica: First edition of the event attracts new investors to the country
The Trade and Investment Promotion Agency of Costa Rica (PROCOMER) will bring together investors from around the world in San José, as part of the first edition of the FDI Summit, which will take place between June 11 and 12, at the Convention...

at 12:10
4 Trends Showing Mental Health is a Continued Challenge for Americans
(Family Features) People with outward appearances of success, productivity and happiness often still deal with internal struggles. Mental health challenges continue to affect Americans, with nearly 3 of 4 (73%) U.S. adults reporting struggles with...

at 12:05
Sunnybrook Dentistry & Braces Takes Part in Sharing Smiles Day to Deliver Free Dental Care to Biloxi Families in Need
Sunnybrook Dentistry & Braces is proud to announce it will join parent company, Benevis, a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, for its ninth annual Sharing...

More news about Health...


News published on and distributed by: